Related Experiment Video
Updated: Feb 18, 2026

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
Published on: May 25, 2018
CRISPR/Cas9 Editing to Facilitate and Expand Drug Discovery
Francis Robert1, Sidong Huang1,2, Jerry Pelletier1,3,2
1Department of Biochemistry, McGill University, Montreal, QC, H3G 1Y6, Canada.
Introduction:
The ability of most laboratories to easily access CRISPR/Cas9 engineering tools has caused a revolution in biology. One of the areas that will continue to be impacted by genome editing is the drug discovery process.
Objective:
CRISPR/Cas9 will not only serve to accelerate the drug discovery pipeline, but also streamline line it by identifying high-value targets, facilitating the validation of drug: target interactions and mechanisms of action, and stimulating the development of phenotype-based high throughput screens as alternatives to target-based assays.
Conclusion:
We review the literature and hurdles that have been overcome to develop the current generation of tools being used to enrich the drug discovery paradigm.
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Homologous Recombination
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

